Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes

NCT02213484 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02213484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02213484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Completed
Start date
July 1, 2014
Completion date
July 1, 2016
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ehlers-danlos type iv syndrome, loeys-dietz syndrome, marfan syndrome, thoracic aortic aneurysm and dissection syndromes, turner syndrome